These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34833096)

  • 1. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
    Tepasse PR; Vollenberg R; Nowacki TM
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
    Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 vaccination in patients with inflammatory bowel disease.
    Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B
    GastroHep; 2021 Jul; 3(4):212-228. PubMed ID: 34539248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
    Khan N; Mahmud N
    Gastroenterology; 2021 Sep; 161(3):827-836. PubMed ID: 34048782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
    Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
    Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological response to vaccination against coronavirus disease-19 in patients with inflammatory bowel disease.
    Mathur A; Sahu S; Rai S; Ghoshal U; Ghoshal UC
    Indian J Gastroenterol; 2023 Feb; 42(1):64-69. PubMed ID: 36598745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.
    Esposito S; Caminiti C; Giordano R; Argentiero A; Ramundo G; Principi N
    Front Immunol; 2022; 13():933774. PubMed ID: 35812420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease.
    Kastl AJ; Brenner EJ; Weaver KN; Zhang X; Strople JA; Adler J; Dubinsky MC; Bousvaros A; Watkins R; Dai X; Chen W; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda EA; Farraye FA; Chun KY; Zikry M; Bastidas M; Firestine AM; Craig RG; Boccieri ME; Long MD; Kappelman MD
    Inflamm Bowel Dis; 2024 Oct; ():. PubMed ID: 39412147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.
    Elkharsawi A; Arnim UV; Schmelz R; Sander C; Stallmach A; Teich N; Walldorf J; Reuken PA
    Z Gastroenterol; 2022 Jan; 60(1):77-80. PubMed ID: 35042256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and Recommendations.
    Murthy SK; Kuenzig ME; Windsor JW; Ghia JE; Griffiths AM; Panaccione R; Seow CH; Benchimol EI; Bernstein CN; Bitton A; Huang JG; Jones JL; Lee K; Kaplan GG; Mukhtar MS; Tandon P; Targownik LE; Gibson DL
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S54-S60. PubMed ID: 34755040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 on Patients with Inflammatory Bowel Disease.
    Ambrose PA; Goodman WA
    J Explor Res Pharmacol; 2022 Mar; 7(1):37-44. PubMed ID: 35966234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study.
    Cao Y; Feng J; Duan S; Yang Y; Zhang Y
    Therap Adv Gastroenterol; 2022; 15():17562848221101722. PubMed ID: 35706827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease.
    Reuken PA; Andreas N; Grunert PC; Glöckner S; Kamradt T; Stallmach A
    J Crohns Colitis; 2022 Feb; 16(2):251-258. PubMed ID: 34379729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
    Ellen Kuenzig M; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia JE; Geist R; Gibson DL; Graff LA; Griffiths AM; Guoxian Huang J; Jones JL; Khanna R; Lakatos PL; Lee K; Mack DR; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Panaccione R; Seow CH; Singh H; Tandon P; Targownik LE; Zelinsky S; Benchimol EI; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S1-S9. PubMed ID: 34755033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
    Moum KM; Moum B; Opheim R
    Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum titer of neutralizing antibodies after COVID-19 vaccination in Japanese patients with inflammatory bowel disease.
    Sugaya T; Takagi T; Uchiyama K; Kajiwara-Kubota M; Asaeda K; Okumura K; Inaba T; Naito Y; Itoh Y
    J Clin Biochem Nutr; 2023 Mar; 72(2):183-188. PubMed ID: 36936870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
    Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
    Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.